Cargando…

Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness

Detalles Bibliográficos
Autores principales:	Flannery, Brendan, Meece, Jennifer K, Williams, John V, Martin, Emily T, Gaglani, Manjusha, Jackson, Michael L, Talbot, H Keipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454355/ https://www.ncbi.nlm.nih.gov/pubmed/32687197 http://dx.doi.org/10.1093/cid/ciaa1023

Ejemplares similares

Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds
por: Gniazdowski, Victoria, et al.
Publicado: (2020)

Bioaerosol Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Referral Center with Critically Ill Coronavirus Disease 2019 (COVID-19) Patients March–May 2020
por: Lane, Morgan A, et al.
Publicado: (2021)

Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis
por: Zeng, Chengbo, et al.
Publicado: (2022)

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019
por: Magleby, Reed, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Serum as Predictor of Severe Outcome in Coronavirus Disease 2019: A Retrospective Cohort Study
por: Hagman, Karl, et al.
Publicado: (2020)

Remote Household Observation for Noninfluenza Respiratory Viral Illness
por: Emanuels, Anne, et al.
Publicado: (2020)

Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts
por: Neilan, Anne M, et al.
Publicado: (2020)

Predictors of Clinical Respiratory Virus Testing Among Adults Hospitalized with Acute Respiratory Illness (ARI) (2015–2016)
por: Strickland, Courtney, et al.
Publicado: (2017)

Dose-response Relation Deduced for Coronaviruses From Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Meta-analysis Results and its Application for Infection Risk Assessment of Aerosol Transmission
por: Zhang, Xiaole, et al.
Publicado: (2020)

The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing
por: Arnaout, Ramy, et al.
Publicado: (2021)

Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce Outbreaks
por: Chin, Elizabeth T, et al.
Publicado: (2020)

150. Relative Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults—United States, 2015–2017
por: Doyle, Joshua, et al.
Publicado: (2018)

Usability and Acceptability of Home-based Self-testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies for Population Surveillance
por: Atchison, Christina, et al.
Publicado: (2020)

Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2–Related Illness in Children: Hospital Experience in Cape Town, South Africa
por: van der Zalm, Marieke M, et al.
Publicado: (2020)

Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
por: Haidar, Ghady, et al.
Publicado: (2021)

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel
por: Swift, Melanie D, et al.
Publicado: (2021)

Rapid Real-time Tracking of Nonpharmaceutical Interventions and Their Association With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity: The Coronavirus Disease 2019 (COVID-19) Pandemic Pulse Study
por: Clipman, Steven J, et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab
por: Yang, Bryant, et al.
Publicado: (2020)

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
por: Burwick, Richard M, et al.
Publicado: (2020)

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores
por: Hoenigl, Martin
Publicado: (2020)

Statewide Interventions and Coronavirus Disease 2019 Mortality in the United States: An Observational Study
por: Yehya, Nadir, et al.
Publicado: (2020)

Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017–2018
por: Boikos, Constantina, et al.
Publicado: (2020)

A Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Prediction Model From Standard Laboratory Tests
por: Bayat, Vafa, et al.
Publicado: (2020)

Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture
por: Pekosz, Andrew, et al.
Publicado: (2021)

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
por: Hensley, Matthew K, et al.
Publicado: (2021)

Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters
por: Zhang, Anna Jinxia, et al.
Publicado: (2020)

Understanding Drivers of Coronavirus Disease 2019 (COVID-19) Racial Disparities: A Population-Level Analysis of COVID-19 Testing Among Black and White Populations
por: Mody, Aaloke, et al.
Publicado: (2020)

Insights on Coronavirus Disease 2019 Epidemiology From a Historic Cruise Ship Quarantine
por: Yamagishi, Takuya, et al.
Publicado: (2020)

Improving Surveillance Estimates of Coronavirus Disease 2019 (COVID-19) Incidence in the United States
por: Rosenberg, Eli S, et al.
Publicado: (2020)

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018
por: Flannery, Brendan L, et al.
Publicado: (2018)

Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018–2019 Influenza Season in the United States
por: Boikos, Constantina, et al.
Publicado: (2021)

Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy
por: Casadevall, Arturo, et al.
Publicado: (2020)

Differential Household Attack Rates Mirror the Ability to Control Coronavirus Disease 2019 (COVID-19)
por: Cook, Alex R, et al.
Publicado: (2020)

Racial Disparities in Coronavirus Disease 2019 (COVID-19) Mortality Are Driven by Unequal Infection Risks
por: Zelner, Jon, et al.
Publicado: (2020)

Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
por: Poston, Daniel, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19) Disparities: A Call for Equity in Health Outcomes and Clinical Research
por: Linas, Benjamin P, et al.
Publicado: (2020)

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
por: Titanji, Boghuma K, et al.
Publicado: (2020)

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
por: Olender, Susan A, et al.
Publicado: (2020)

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study
por: Rogers, Ralph, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ajb2hsv8f39gpe6tsis2qkqvil